Loading...

Innovative Eyewear, Inc.

LUCYWNASDAQ
Healthcare
Medical - Instruments & Supplies
$0.06
$0.003(5.09%)
U.S. Market opens in 13h 45m

Innovative Eyewear, Inc. Fundamental Analysis

Innovative Eyewear, Inc. (LUCYW) shows moderate financial fundamentals with a PE ratio of -0.71, profit margin of -2.72%, and ROE of -0.36%. The company generates $0.0B in annual revenue with strong year-over-year growth of 41.99%.

Key Strengths

Cash Position1517.38%
PEG Ratio-0.01
Current Ratio8.02

Areas of Concern

ROE-0.36%
Operating Margin-3.01%
We analyze LUCYW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -139.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-139.8/100

We analyze LUCYW's fundamental strength across five key dimensions:

Efficiency Score

Weak

LUCYW struggles to generate sufficient returns from assets.

ROA > 10%
-85.67%

Valuation Score

Excellent

LUCYW trades at attractive valuation levels.

PE < 25
-0.71
PEG Ratio < 2
-0.01

Growth Score

Excellent

LUCYW delivers strong and consistent growth momentum.

Revenue Growth > 5%
41.99%
EPS Growth > 10%
59.04%

Financial Health Score

Excellent

LUCYW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
8.02

Profitability Score

Weak

LUCYW struggles to sustain strong margins.

ROE > 15%
-35.72%
Net Margin ≥ 15%
-2.72%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is LUCYW Expensive or Cheap?

P/E Ratio

LUCYW trades at -0.71 times earnings. This suggests potential undervaluation.

-0.71

PEG Ratio

When adjusting for growth, LUCYW's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Innovative Eyewear, Inc. at 0.69 times its book value. This may indicate undervaluation.

0.69

EV/EBITDA

Enterprise value stands at -0.91 times EBITDA. This is generally considered low.

-0.91

How Well Does LUCYW Make Money?

Net Profit Margin

For every $100 in sales, Innovative Eyewear, Inc. keeps $-2.72 as profit after all expenses.

-2.72%

Operating Margin

Core operations generate -3.01 in profit for every $100 in revenue, before interest and taxes.

-3.01%

ROE

Management delivers $-0.36 in profit for every $100 of shareholder equity.

-0.36%

ROA

Innovative Eyewear, Inc. generates $-85.67 in profit for every $100 in assets, demonstrating efficient asset deployment.

-85.67%

Following the Money - Real Cash Generation

Operating Cash Flow

Innovative Eyewear, Inc. generates strong operating cash flow of $2.43B, reflecting robust business health.

$2.43B

Free Cash Flow

Innovative Eyewear, Inc. generates strong free cash flow of $2.43B, providing ample flexibility for dividends, buybacks, or growth.

$2.43B

FCF Per Share

Each share generates $490.98 in free cash annually.

$490.98

FCF Yield

LUCYW converts 828.29% of its market value into free cash.

828.29%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.71

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.69

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.24

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.006

vs 25 benchmark

Current Ratio

Current assets to current liabilities

8.02

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.86

vs 25 benchmark

ROCE

Return on capital employed

-1.07

vs 25 benchmark

How LUCYW Stacks Against Its Sector Peers

MetricLUCYW ValueSector AveragePerformance
P/E Ratio-0.7128.65 Better (Cheaper)
ROE-0.36%795.00% Weak
Net Margin-272.48%-49787.00% (disorted) Weak
Debt/Equity0.010.40 Strong (Low Leverage)
Current Ratio8.023.73 Strong Liquidity
ROA-85.67%-20255.00% (disorted) Weak

LUCYW outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Innovative Eyewear, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

2155.92%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-96.54%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ